A new treatment algorithm for advanced otosclerosis, based on the clinical experience of Dutch investigators and supported by a literature review they conducted, suggests that the window for successful cochlear implantation (CI) in patients with severe disease is narrower than some otolaryngologists may believe .
As the physicians of the baby boomer generation approach their golden years, many have achieved career and financial success and are looking for an arrangement that will allow them to ease into retirement. While you may not be ready to hang up your white coat permanently, you may be interested in working fewer hours and taking less call. Retirement requires more than simply removing your name from the office door, however. If you are a physician nearing retirement, it is important that you plan, discuss and make contractual agreements that will allow you to accomplish your goals and changing needs.
The opportunity to gain more surgical experience as a facial plastics fellow was enticing to Hussein Samji, MD, MPH, as he finished his residency at Stanford University School of Medicine in Palo Alto, Calif., in 2010. But after exposure to some of the more mundane aspects of the subspecialty during screening interviews, Dr. Samji said he knew it wasn’t the career path for him.
The Patient Protection and Affordable Care Act of 2010 (ACA) is described as the most sweeping health care legislation passed in the U.S. since Medicare’s implementation in 1965. The health reform law is already changing the health care system, but the most profound modifications are yet to come. The law will affect otolaryngologists’ practices in many ways, both direct and indirect. Here are some areas of the law to consider.
October 1, 2013 should be on the mind of every physician in the U.S. That is the day when a new diagnostic coding system will be instituted, the first such change since 2003. The implementation’s aftermath is predicted to be anywhere from a normal day at the office to financial Armageddon.
Maintaining sinus patency after functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS) has long been an issue; as many as 23 to 47 percent of patients require revision surgery after FESS. Now, a new drug-eluting, bioabsorbable stent manufactured by Intersect (Palo Alto, Calif.) is being billed as a “breakthrough treatment [that] improves outcomes for sinus surgery,” according to a news release from the company. The device, which received pre-market approval from the U.S. Food and Drug Administration (FDA) in August, has been studied since 2008. It is currently available in Texas, New York, Philadelphia, New Jersey, Atlanta, Ohio and Kentucky.
Born in Council Bluffs, Iowa, Patrick Edgar Brookhouser, MD, grew up in Missouri Valley, Iowa, where he graduated valedictorian from the local high school. His intellect and natural curiosity earned him numerous academic awards, and he graduated from Creighton University summa cum laude and from Johns Hopkins Medical School as a member of Alpha Omega Alpha.
Oral appliances may work better than CPAP for some patients
What are the risk factors for the frequency and severity of bleeding episodes following tonsillectomy (TE), tonsillotomy (TO) or adenoidectomy (AE)? Background: TE, TO and AE are the most frequent surgeries […]
What is the experience in using a superficial muscoloaponeurotic system (SMAS)-platysma flap in facial-aesthetic parotid surgery for benign parotid neoplasms? Background: The surgical management of benign parotid neoplasms has evolved from […]